Project Grant R01EY036082
- This Project Grant award of $493,642, provided by the National Eye Institute (CFDA 93.867 - Vision Research), supports a research project to identify and locate geographic clusters of vision and eye health problems using secondary surveillance data. The key products and services to be delivered under this award include: Developing an application to access public use files from the CDC-funded Vision and Eye Health Surveillance System (VEHSS) to conduct scan statistical analyses and report...
- This $417,162 Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) supports research on using optical techniques to detect early signs of glaucoma, the leading cause of irreversible blindness worldwide. The University of Houston System, the grantee, will conduct research to determine if changes in the birefringence (optical properties) of the lamina cribrosa and posterior eye structures can serve as sensitive early indicators of glaucoma before structural damage...
- The National Eye Institute (NEI) awarded a $616,316 Project Grant to the Regents of the University of Michigan, effective July 1, 2025 through June 30, 2027, under the Vision Research federal grant program (CFDA 93.867). The purpose of this grant is to develop a multi-modal, hands-free user interface embedded in a glasses frame to provide non-visual guidance for navigation and improve the functionality and usability of existing smartphone-based assistive technology for the over 7 million...
- The Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) supports the development of an accurate, non-invasive, and automated 24-hour intraocular pressure (IOP) monitoring device. The overarching goal is to create a wearable IOP monitor that can improve the clinical management of glaucoma, the leading cause of irreversible blindness. The $713,964 award will fund research activities over a 5-year period from March 2025 to February 2030 at the University of California,...
- This $459,286 Project Grant award from the National Eye Institute's Vision Research program (CFDA 93.867) supports the development of clinically-motivated and explainable machine learning-based image classifiers to detect trachoma, a leading infectious cause of vision loss worldwide. The primary objectives are to: 1) create a smartphone-based application to standardize trachoma image acquisition and identify low-quality images, 2) improve the performance of an existing machine learning model...
- This federal Project Grant award of $315,825.00 from the National Eye Institute (CFDA 93.867 Vision Research) supports the development of a new, non-invasive, remote photonic technology for intraocular pressure (IOP) biomonitoring in glaucoma patients. The technology, called Photonic IOP Biomonitoring (PIB), uses sound waves and laser speckle pattern monitoring to deduce IOP without the need for physical eye contact or clinician interpretation. The goal is to miniaturize PIB into monoculars or...
- This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) supports the development of a novel, noninvasive, and sensitive diagnostic method to measure retinal dysfunction. The $491,466 award will fund research at the University of California, San Francisco (UCSF) from January 1, 2025 to December 31, 2026. The project aims to create a scalable diagnostic tool that can detect the earliest signs of retinal diseases like diabetic retinopathy and retinitis pigmentosa,...
- This Project Grant award of $393,175.00 from the National Eye Institute (CFDA 93.867 - Vision Research) is supporting the implementation and evaluation of instrument-based vision screening in primary care pediatric offices affiliated with Akron Children's Hospital. The goal is to enhance early detection of sight-threatening disorders in young children (ages 3-5) within the hospital's service area. Since the project's implementation in April 2021, the awardee has demonstrated a significant...
- This is a Cooperative Agreement award from the National Eye Institute (NEI), part of the U.S. Department of Health and Human Services, under the Vision Research federal grant program (CFDA 93.867). The $791,994 award, which began on September 1, 2025, supports the development of a next-generation ophthalmic microscope with integrated optical coherence tomography (OCT) imaging capabilities. The project aims to overcome limitations of current ophthalmic surgery microscopes by enabling more...
- This $1,620,537 federal Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) supports research at Northwestern University to model aqueous humor outflow and develop a digital twin of the anterior eye to improve the understanding and treatment of glaucoma. The project aims to enhance minimally invasive glaucoma surgery (MIGS) efficacy by better characterizing the circumferential anatomy and pathophysiology of aqueous humor outflow, which currently limits the...
This $735,937 Project Grant, awarded by the National Eye Institute (CFDA 93.867 - Vision Research), aims to test the effectiveness of a technology-based approach to screening for glaucoma and other eye diseases at Federally Qualified Health Centers (FQHCs). The University of Michigan, as the primary awardee, will utilize digital ophthalmic data captured by FQHC technicians to help eye doctors at the FQHCs triage patients to appropriate care, including 30-minute detailed visits or 10-minute wellness visits. The project also involves ophthalmic technicians acting as healthcare navigators to help patients access affordable glasses and recommended medical treatment. The award period runs from August 1, 2025 to March 31, 2030. This research seeks to address the critical need for more effective and cost-effective strategies to screen for eye diseases in the FQHC patient population, who are more likely to have undiagnosed and untreated conditions like glaucoma.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $735.9k | 8/1/25 |